Skip to main content
. 2016 Jul 15;15(17):2256–2262. doi: 10.1080/15384101.2016.1208872

Figure 2.

Figure 2.

The association of EZH2 transcript levels to metastatic prostate cancer is driven by proliferation. Plots of EZH2 transcript levels in primary and metastatic prostate cancer (data extracted from ref. 49) before (left) and after (right) adjustment to the proliferation metagene (as described by ref. 30). p-value of unpaired t-tests are displayed.